These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23613003)

  • 21. Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.
    Oh DY; Kim TY; Kwon JH; Lee JJ; Joh Y; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2005 Jul; 35(7):380-5. PubMed ID: 15976069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In the nick of time: arterial thrombosis on starting combination chemotherapy in metastatic gastric adenocarcinoma.
    Boon IS; Boon CS
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26917797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified DCF regimen as primary treatment for patients with metastatic gastric cancer.
    Koca D; Dogan E; Yardim H; Duzen O; Karaca S
    J BUON; 2013; 18(2):377-84. PubMed ID: 23818349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
    Ajani JA; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Awad L; Van Cutsem E;
    J Clin Oncol; 2007 Aug; 25(22):3210-6. PubMed ID: 17664468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience.
    Ben Aharon I; Purim O; Kundel Y; Brenner R; Gordon N; Sulkes A; Brenner B
    Anticancer Drugs; 2012 Mar; 23(3):313-20. PubMed ID: 22241172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer.
    Quintero-Aldana G; Jorge M; Grande C; Salgado M; Gallardo E; Varela S; López C; Villanueva MJ; Fernández A; Alvarez E; González P; Castellanos J; Casal J; López R; Campos Balea B
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):731-7. PubMed ID: 26242221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.
    Kos FT; Uncu D; Ozdemir N; Budakoglu B; Odabaş H; Abali H; Oksuzoglu B; Aksoy S; Zengin N
    Chemotherapy; 2011; 57(3):230-5. PubMed ID: 21597287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
    Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
    Van Cutsem E; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Risse ML; Ajani JA;
    J Clin Oncol; 2006 Nov; 24(31):4991-7. PubMed ID: 17075117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombectomy in HIV related peripheral arterial thrombosis: a preliminary report.
    Mulaudzi TV; Robbs JV; Pillay W; Pillay B; Moodley J; Magagula T; Thusini ZC
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):102-6. PubMed ID: 15933991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
    Ajani JA; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Marabotti C; Van Cutsem E;
    J Clin Oncol; 2007 Aug; 25(22):3205-9. PubMed ID: 17664467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Castleman's disease and arterial thrombosis: result of excessively elevated interleukin-6 plasma level?
    Schumacher A; Jacomella V; Stüssi G; Amann-Vesti B; Corti N; Husmann M
    Vasa; 2012 Mar; 41(2):145-8. PubMed ID: 22403134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Emergencies in angiology].
    Mahler F
    Schweiz Med Wochenschr; 1993 May; 123(17):868-72. PubMed ID: 8497773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
    Amini A; Sanati H
    Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trousseau's syndrome in a patient with advanced stage gastric cancer.
    Chien TL; Rau KM; Chung WJ; Tai WC; Wang SH; Chiu YC; Wu KL; Chou YP; Wu CC; Chen YH; Chuah SK;
    World J Gastroenterol; 2015 Sep; 21(34):10049-53. PubMed ID: 26379411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
    Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
    Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of far-advanced gastric cancer treated with continuous 5-fluorouracil injection and intrahepatic arterial infusion of low-dose cisplatin].
    Ueno T; Oka M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1855-7. PubMed ID: 9382550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer.
    Yamamoto K; Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
    Anticancer Res; 2009 Oct; 29(10):4211-5. PubMed ID: 19846975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.